| Ischemic preconditioning and clinical scenarios. | |
MedLine Citation:
|
PMID: 23197083 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: Ischemic preconditioning (IPC) is gaining attention as a novel neuroprotective therapy and could provide an improved mechanistic understanding of tolerance to cerebral ischemia. The purpose of this article is to review the recent work in the field of IPC and its applications to clinical scenarios. RECENT FINDINGS: The cellular signaling pathways that are activated following IPC are now better understood and have enabled investigators to identify several IPC mimetics. Most of these studies were performed in rodents, and efficacy of these mimetics remains to be evaluated in human patients. Additionally, remote ischemic preconditioning (RIPC) may have higher translational value than IPC. Repeated cycles of temporary ischemia in a remote organ can activate protective pathways in the target organ, including the heart and brain. Clinical trials are underway to test the efficacy of RIPC in protecting brain against subarachnoid hemorrhage. SUMMARY: IPC, RIPC, and IPC mimetics have the potential to be therapeutic in various clinical scenarios. Further understanding of IPC-induced neuroprotection pathways and utilization of clinically relevant animal models are necessary to increase the translational potential of IPC in the near future. |
Authors:
|
Srinivasan V Narayanan; Kunjan R Dave; Miguel A Perez-Pinzon |
Related Documents
:
|
20963853 - Adverse outcome pathways and ecological risk assessment: bridging to population-level e... 7252373 - Convergence to genetically uniform state in stepping stone models of population genetics. 20503993 - New estimators for calculating solvation entropy and enthalpy and comparative assessmen... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review |
Journal Detail:
|
Title: Current opinion in neurology Volume: 26 ISSN: 1473-6551 ISO Abbreviation: Curr. Opin. Neurol. Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2013-01-10 Completed Date: 2013-06-25 Revised Date: 2013-08-28 |
Medline Journal Info:
|
Nlm Unique ID: 9319162 Medline TA: Curr Opin Neurol Country: England |
Other Details:
|
Languages: eng Pagination: 1-7 Citation Subset: IM |
Affiliation:
|
Department of Neurology, Cerebral Vascular Disease Research Center, University of Miami, Miller School of Medicine, Miami, Florida, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Brain Ischemia / prevention & control* Disease Models, Animal Humans Ischemic Preconditioning* Organelles / physiology Oxidative Stress / physiology Signal Transduction / physiology |
| Grant Support | |
ID/Acronym/Agency:
|
F31 NS080344/NS/NINDS NIH HHS; F31 NS080344-01/NS/NINDS NIH HHS; NS054147/NS/NINDS NIH HHS; NS073779/NS/NINDS NIH HHS; NS34773/NS/NINDS NIH HHS; NS45676/NS/NINDS NIH HHS; R01 NS045676/NS/NINDS NIH HHS; R01 NS054147/NS/NINDS NIH HHS; R01 NS073779/NS/NINDS NIH HHS; R29 NS034773/NS/NINDS NIH HHS |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients.
Next Document: Stereoselective Synthesis and NMR Characterization of C-24 Epimeric Pairs of 24-Alkyl Oxysterols.